ANZGOG’s 2026 Annual Scientific Meeting (ASM) invites us to shift our focus forward. It’s a call to action: to ask what’s next, to push boundaries, and to translate today’s innovation into the impact of tomorrow.

We are at a pivotal point. Advances in artificial intelligence are reshaping every aspect of oncology. The urgent need for pragmatic trials is more apparent than ever, particularly for our rarer tumour types. Evolving molecular insights are transforming diagnostics and treatment. And critically, the lived experience of survivors continues to guide and enrich the research landscape. This is a time for collective action—and ANZGOG’s 2026 ASM is where these essential conversations will take place.

ANZGOG’s ASM is a dynamic forum that brings together national and international experts in gynaecological medicine, radiation and surgical oncology, pathology, basic scientists, translational and quality of life researchers, study coordinators and nurses, as well as our partners in the pharmaceutical industry for bold thinking, practical collaboration, and action-oriented discussion about the future of gynaecological cancer research.